Literature DB >> 19342728

Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.

Ignazio Olivieri, Angela Padula, Pietro Leccese, Salvatore D'Angelo, Vincenzo Giasi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19342728     DOI： 10.3899/jrheum.081063

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.

Authors:  Michal Schaap-Fogler; Radgonde Amer; Ronit Friling; Ethan Priel; Michal Kramer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-12-24       Impact factor: 3.117

2.  Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Olga Kaloudi; Emanuele Cassarà; Massimo Susini; Ivo Lenzetti
Journal:  Biologics       Date:  2011-12-29

Review 3.  Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.

Authors:  Cinzia Rotondo; Giuseppe Lopalco; Florenzo Iannone; Antonio Vitale; Rosaria Talarico; Mauro Galeazzi; Giovanni Lapadula; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2015-06-22       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.